ArticleJournal of chemical information and modeling2026
Combined Modeling Approaches for Assessing Sodium-Iodide Symporter Inhibition.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The sodium-iodide symporter (NIS, SLC5A5) plays a crucial role in thyroid hormone synthesis. Especially during brain development, correct thyroid signaling is of critical importance. Hence, inhibition of this transporter can lead to neurodevelopmental disorders, such as lowered IQ or autism. In order to uncover environmental chemicals with the potential of causing developmental neurotoxicity (DNT), NIS was selected for modeling. To support next-generation risk assessment, in silico-based methods were utilized. Docking-based virtual screening workflows of a library of compounds with experimentally determined inhibitory activity on NIS were applied. In addition, machine learning (ML) models based on random forest (RF), extreme gradient boosting (XGB), and support vector machines (SVM) were trained using extended-connectivity fingerprints 4 (ECFP4) and continuous and data-driven descriptors (CDDDs) with 9-fold cross validation to discriminate between NIS inhibiting and noninhibiting compounds. Ultimately, combining ML and docking predictions improved discrimination, achieving an area under the receiver operating characteristic curve (ROC AUC) of 0.77. Thresholds for optimal discrimination between actives and inactives were determined using kernel density estimate plots, at which a Matthews correlation coefficient (MCC) of 0.32, and a balanced accuracy (BA) of 0.78 were achieved on the internal test set. By combining ML predictions with docking scores and training on a larger, more diverse data set of 1412 compounds, this study provides a novel and robust framework for NIS inhibition prediction, which constitutes a new approach method in toxicological risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.